ACP Video Intervention for Patients With Life-Limiting Illness

NCT ID: NCT04778761

Last Updated: 2026-01-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-04-01

Study Completion Date

2027-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this research is to increase patients' knowledge about advance care planning (ACP) discussions and hospice care for patients with serious illness receiving home-based care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

ACP is a process that allows patients to communicate their wishes and preferences or medical care, when they are seriously ill, to their medical providers. The study investigators would like to assess whether a home-ACP video can improve patient-clinician communication about patients wishes for their medical care and lead to more patient-centered care.

This study is a randomized clinical trial of a Home-ACP intervention among 500 adult patients with serious illness receiving medical care at home with the Clover Health House Calls Program. Study participants will be assigned to one of two groups. In one group, participants will continue to receive usual care with their home-based care team. In the second group, participants will continue to receive their usual care with their home-based care team and also view an ACP video that helps them understand ACP and provides education about ACP and hospice care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Health Care Utilization End Stage Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors
The research team collecting study outcomes will be blinded to group assignment

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual Care

Usual care entails receiving usual medical care by the home-based care team.

Group Type NO_INTERVENTION

No interventions assigned to this group

Video intervention

In addition to usual care, the intervention will entail having a visit by a trained study clinician to provide access to the ACP video. The study clinician will discuss the content of the video and answer any questions.

Group Type EXPERIMENTAL

Home ACP Video

Intervention Type BEHAVIORAL

A video focused on Advance Care Planning and Hospice for patients with serious illness

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Home ACP Video

A video focused on Advance Care Planning and Hospice for patients with serious illness

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 21 or over
* Have a one-year prognosis or less as determined by Clover Health's validated algorithm
* Speak either English or one of the other 25 languages in which the video intervention is available

Exclusion Criteria

* Visually impaired beyond 20/200 corrected
* Acute psychiatric illness or other comorbid condition that impairs cognitive ability to participate in advance care planning discussion as determined by the primary House Call Provider.
Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

El-Jawahri, Areej,M.D.

Assistant Professor Of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clover Health

Jersey City, New Jersey, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Areej El-Jawahri, MD

Role: CONTACT

617-724-4000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kumar Dharmarajian, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020P001277

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Advanced Dementia and End-of-life
NCT03548142 COMPLETED NA